London, UK – 28 September, 2023 – Evaluate, a leading provider of life sciences data and insights, and Galen Growth, the global leader in Digital Health data, intel and insights, today announced a commercial partnership to bring HealthTech Alpha to a broader market.
HealthTech Alpha is the number one choice for Digital Health insights for leading pharmaceutical, medical devices, insurers, business consultants, financial services, amongst many others. The platform provides the most comprehensive view of the Digital Health market, including market trends, competitive landscape, and insights into emerging technologies.
Under the terms of the partnership, Evaluate, a Norstella company, will be the exclusive reseller of HealthTech Alpha across the globe. The partnership will enable Evaluate to offer its customers a full range of healthcare data and insights and help them make better pipeline and portfolio decisions.
“Digital Health is a hugely important, fast-moving and innovative area of the healthcare space,” said Mike Gallup, CEO at Norstella. “The partnership with Galen Growth will enable our clients to add a critical digital component to the in-depth biopharma and medtech insights within our solutions. The additional of a digital lens on the market will support Norstella’s mission of smoothing the path to therapy from pipeline to patient.” “We are delighted to partner with Evaluate,” said Julien de Salaberry, CEO and founder of Galen Growth. “Evaluate is a highly respected leader in the healthcare data and insights market, and we believe this partnership will help us accelerate the growth of HealthTech Alpha. We look forward to working together to bring this valuable resource to market.
About Evaluate Ltd
Since 1996, Evaluate, a Norstella company, has provided the life sciences industry with the data, insight and intelligence to facilitate confident decision making on high-value investments in treatments and markets. We enable our clients to embed our proprietary and industry data into their workflows, tools and processes so they can work more effectively and efficiently. For more information about Evaluate, visit https://www.evaluate.com/and follow us on LinkedIn and Twitter.
Norstella consists of several prominent pharmaceutical solutions providers—Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group. United by a shared mission, to help patients gain access to life-saving therapies. Norstella offers comprehensive insights throughout the drug development lifecycle, leveraging unparalleled data, cutting-edge technology, and expert insights and consultancy. For more information, visit Norstella and follow on LinkedIn.
About Galen Growth
Galen Growth is the global leader in Digital Health data, intel and insights. The company provides the most comprehensive view of the Digital Health market, including market trends, competitive landscape, and insights into emerging technologies. Galen Growth’s customers include leading pharmaceutical companies, medical device manufacturers, insurers, and institutional investors. For more information, visit Galen Growth and follow us on LinkedIn and Twitter.
For more information, please contact:
FOR GALEN GROWTH:
Julien de Salaberry, CEO /Founder